S2 E5: AAM's Dan Leonard on What's Next for Generic Drugs and Biosimilars

Share:

Redeeming Value

Miscellaneous


The Association for Accessible Medicines' new president and CEO, Dan Leonard, goes behind the mic to talk about the pathway to his new gig, the promise of biosimilars, what the 2020 election means for the generic drug industry, and why COVID-19 has underscored the public health impact of generic drugs.  Keep up with Dan on Twitter.